SUSQUEHANNA INTERNATIONAL GROUP, LLP - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 37 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2016. The put-call ratio across all filers is 16.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2016$5,000
-70.6%
11,071
-55.8%
0.00%
Q3 2016$17,000
-66.0%
25,023
+0.9%
0.00%
Q2 2016$50,000
+42.9%
24,800
+69.9%
0.00%
Q1 2016$35,000
-97.6%
14,600
-92.4%
0.00%
Q4 2015$1,472,000
+244.7%
191,900
+137.9%
0.00%
Q3 2015$427,000
+24.5%
80,677
+110.6%
0.00%
Q2 2015$343,000
+152.2%
38,300
+78.1%
0.00%
Q1 2015$136,000
-77.4%
21,500
-75.6%
0.00%
Q3 2014$603,00088,0170.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2016
NameSharesValueWeighting ↓
FNY Managed Accounts LLC 75,000$35,258,0000.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 696,455$327,0000.02%
Klingman & Associates, LLC 10,000$5,0000.00%
BLUESTEIN R H & CO LLC 76,500$36,0000.00%
OPPENHEIMER & CO INC 73,500$34,0000.00%
Renaissance Technologies 774,603$364,0000.00%
Walleye Trading LLC 6$00.00%
Bank of New York Mellon Corp 16,660$8,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,071$5,0000.00%
SIMPLEX TRADING, LLC 200$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders